Theranica Bioelectronics announced Monday it has established a new subsidiary, Theranica USA, based in Montclair.
Theranica is a biomedical technology company based in Netanya, Israel, which develops electroceuticals for migraine and other pain disorders.
The company also announced it has appointed Scott Szymanski as president of Theranica USA, David Warshawsky as vice president of business development and operations, and Alix Bennett as senior director of medical affairs.
The group will be responsible for commercializing Nerivio, a smartphone-controlled wearable device for acute treatment of migraine.
“Szymanski, Warshawsky and Bennett make a highly skilled team, the core leadership of the newly established Theranica USA. They will lead the launch of our innovative, affordable, non-invasive, drug-free alternative for acute migraine in the US,” Alon Ironi, CEO and co-founder of Theranica.
